ArticleJournal of medical virology2021

SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.

Lulu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.